PubMed · 15457965
[Hepatitis C].
Abstract
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we briefly review the virology, diagnosis and therapy of hepatitis C. Standard therapy with pegylated interferon-alpha and ribavirin results in a sustained virological response in 40-50% of genotype 1- and in about 80% of genotype 2- or 3-infected patients. Recent progress has allowed the identification of novel antiviral targets and therapeutic strategies. These will likely complement existing therapeutic modalities in the near future.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
D Moradpour, H E Blum. 2004. [Hepatitis C].. https://doi.org/10.1024/0040-5930.61.8.493
Cite the original work for its findings. Save a collection to share your selection of sources.